Monthly Archives: November 2015

New Mexico City Airport Will Debottleneck ASR, PAC and OMAB.

The completion of a 50 million passenger per annum airport in Mexico City has major implications for the passenger traffic flows to airports operated by Grupo Aeroportuario Del Sureste (ASR-NYSE, $161.38), Grupo Aeroportuario Del Pacifico (PAC-NYSE, $95.37) and Grupo Aeroportuario

Posted in Open Blog

Gilead Sciences (GILD-NASDAQ, $103.81) Financial Modelling for Zydelig

CLL is diagnosed in roughly 15,700 persons annually in the United States. https://www.lls.org/sites/default/files/file_assets/facts.pdf GILD has announced that the success rate of their drug Zydelig has been so successful that the study data resulted in an unbinding of the placebo control

Posted in Portfolio Model Subscription

The end for the Pharmaceutical Bull Cycle?

The denouement of a sectoral investment trend is characteristically well telegraphed. A cable transmission is received. Typically terse, it notes either the demise of, or the malfeasance by, a much admired and widely held company and is generally read in

Posted in Open Blog